LexAurum Advisors LLC Has $569,000 Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

LexAurum Advisors LLC lowered its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,952 shares of the pharmacy operator’s stock after selling 1,600 shares during the quarter. LexAurum Advisors LLC’s holdings in Walgreens Boots Alliance were worth $569,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the stock. Raymond James Financial Inc. acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth approximately $9,685,000. First Trust Advisors LP acquired a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at $368,000. Venturi Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at $28,000. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Walgreens Boots Alliance by 45.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 82,502 shares of the pharmacy operator’s stock valued at $794,000 after purchasing an additional 25,962 shares in the last quarter. Finally, Cibc World Markets Corp boosted its holdings in shares of Walgreens Boots Alliance by 15.2% in the 4th quarter. Cibc World Markets Corp now owns 282,286 shares of the pharmacy operator’s stock valued at $2,634,000 after purchasing an additional 37,141 shares in the last quarter. 58.59% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

WBA has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their price objective for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Wall Street Zen assumed coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, May 21st. They issued a “hold” rating on the stock. Finally, Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $10.59.

Insider Buying and Selling

In other Walgreens Boots Alliance news, Chairman Stefano Pessina bought 832,258 shares of the stock in a transaction that occurred on Sunday, April 27th. The shares were bought at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the acquisition, the chairman now directly owns 145,621,079 shares of the company’s stock, valued at approximately $1,603,288,079.79. The trade was a 0.57% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 17.50% of the stock is owned by company insiders.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $11.25 on Monday. The company has a market capitalization of $9.73 billion, a PE ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.78. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $16.25. The stock’s 50-day moving average price is $11.04 and its two-hundred day moving average price is $10.60. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $38.59 billion for the quarter, compared to the consensus estimate of $37.90 billion. During the same period in the previous year, the business earned $1.20 EPS. The firm’s revenue was up 4.1% compared to the same quarter last year. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.